Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GTX Inc (NASDAQ:GTXI)

0.56
Delayed Data
As of Jul 28
 0.00 / 0.00%
Today’s Change
0.29
Today|||52-Week Range
1.22
-20.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$79.4M

Company Description

GTx, Inc. engages in the research and development of biopharmaceutical products. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN.

Contact Information

GTx, Inc.
175 Toyota Plaza
Memphis Tennessee 38103
P:(901) 523-9700
Investor Relations:

Employees

Shareholders

Other institutional9.86%
Individual stakeholders70.61%
Mutual fund holders1.00%

Top Executives

Marc Steven HanoverChief Executive Officer & Class I Director
Jason T. ShackelfordPrincipal Financial & Accounting Officer
Diane C. YoungChief Medical Officer & Vice President
Henry Patton DoggrellSecretary, Chief Legal Officer & Vice President
Jeffrey G. HesselbergVice President-Regulatory Affairs